Suzhou Suncadia Biopharmaceuticals Co., Ltd. clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
What changed in the last 30 days
6 trials changed in the last 30 days: 0 stopped, 5 with notable changes, 1 with a minor change only.
- Notable: SHR-A2009 Combined With Other Anti-tumor Therapies for Perioperative Treatment of Resectable Non-small Cell Lung Cancer Recruitment opened
- Notable: Treatment of MIBC · SHR-A2102 Injection Combined With Adebrelimab (SHR-1316) Primary endpoint(s) modified
- Minor: SHR-1701 in Combination With Chemotherapy and Radiotherapy in Locally Advanced Rectal Cancer Changed Registry marked status Unknown (sponsor has not verified the record since Mar 2022); last known: Recruiting
- Notable: Trials Comparing Trastuzumab Plus Bevacizumab With Bevacizumab as First-line Maintenance Therapy for Epithelial Ovarian Cancer Recruitment opened
- Notable: SHR-4595 Injection · Advanced Solid Tumors to Evaluate Safety, Tolerability and Pharmacokinetics Recruitment opened
- Notable: TACE in Combination With SHR-8068, Adebrelimab, and Bevacizumab Versus TACE · Incurable Hepatocellular Carcinoma Start date pushed from Sep 2026 to Nov 2026
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-26 | NCT07895992 SHR-A2009 Combined With Bevacizumab in the Treatment of Locally Advanced or Metastatic… | Phase 3 | Not Yet Recruiting |
| 2026-10-26 | NCT07896005 A Study of SHR-A1811 Combined With Adebrelimab for the First-line HER2-overexpressing… | Phase 3 | Not Yet Recruiting |
Active trials by phase
| Phase 1 | 18 | |
| Phase 1/2 | 13 | |
| Phase 2 | 15 | |
| Phase 2/3 | 2 | |
| Phase 3 | 24 | |
| Phase 4 | 1 |
Disease areas by active trials, top 10 of 23
Lung Cancer (12) · Non-Small Cell Lung Cancer (NSCLC) (11) · Bladder Cancer (4) · Cholangiocarcinoma (4) · Colorectal Cancer (4) · Liver Cancer (4) · Gastric Cancer (3) · Ovarian Cancer (3) · Psoriasis (3) · Breast Cancer (2)
Get alerts when Suzhou Suncadia Biopharmaceuticals Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.